HIGHLIGHTS
- who: Pancreatic Cancer and collaborators from the Department of Medical Oncology, Dana-Farber Institute, Boston, MA, USA Herbert Irving Comprehensive Center, Columbia University Irving Medical Center, New York, NY, USA have published the Article: Phase Ib and Expansion Study of Gemcitabine, Nab - Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer, in the Journal: (JOURNAL)
- what: The aim of this study was to evaluate the safety profile and clinical efficacy of ficlatuzumab (AV-299), in combination with standard systemic chemotherapy of gemcitabine and albumin-bound paclitaxel in patients with metastatic PDAC. The secondary objectives, this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.